Receptor affinities of dopamine D1 receptor-selective novel phenylbenzazepines

By Neumeyer J.L.   Kula N.S.   Bergman J.   Baldessarini R.J.  

European Journal of Pharmacology, Vol. 474, Iss. 2, 2003-08 ,pp. : 137-140

Elsevier

Access to resources Recommend Favorite

The dopamine D₁ receptor agonist and D₂ receptor antagonist LEK-8829 attenuates reinstatement of cocaine-seeking in rats

By Milivojevič Nataša   Krisch Igor   Sket Dušan   Živin Marko  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 369, Iss. 6, 2004-06 ,pp. : 576-582

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacological Survey of Medicinal Plants for Activity at Dopamine Receptor Subtypes. II. Screen for Binding Activity at the D1 and D2 Dopamine Receptor Subtypes

By Luedtke Robert R.   Freeman Rebekah A.   Volk Michael   Arfan Mohammad   Reinecke Manfred G.  

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 41, Iss. 1, 2003-02 ,pp. : 45-58

Informa Healthcare

Access to resources Recommend Favorite

A-315456: a selective 1D -adrenoceptor antagonist with minimal dopamine D 2 and 5-HT 1A receptor affinity

By Buckner S.A.   Milicic I.   Daza A.   Lynch J.J.   Kolasa T.   Nakane M.   Sullivan J.P.   Brioni J.D.  

European Journal of Pharmacology, Vol. 433, Iss. 1, 2001-12 ,pp. : 123-127

Elsevier

Access to resources Recommend Favorite

Dopamine D1 receptor agonists as antiparkinson drugs

By Mailman R.B.   Nichols D.E.  

Trends in Pharmacological Sciences, Vol. 19, Iss. 7, 1998-07 ,pp. : 255-256

Elsevier

Access to resources Recommend Favorite